drugset / Trial / NCT00804752

Vitamin D Treatment in Patients With Chronic Hepatitis C

NCT00804752 ↗

Summary

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 1000 iu —